Genentech Research and Early Development
Affiliated withGenentech Research and Early DevelopmentRancho Biosciences, LLC
Research Area
Zachary Whitfield has not added Biography.
If you are Zachary Whitfield and would like to personalize this page please email our Author Liaison for assistance.
Article Total : 1 | Year |
|---|---|
| 2026 |
Article | Year |
|---|---|
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models. Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 41143603 | 2026 |